PHARMACEUTICAL SOLUTIONS USED DIALYSIS

Brand Owner (click to sort) Address Description
CALRYPLAZE GAMBRO LUNDIA AB 16 Magistratsvagen Lund 22643 Sweden Pharmaceutical solutions used in dialysis, namely, dialysis fluids, dialysis substitution fluids or concentrates, all being for use in hemodialysis, hemofiltration or hemodiafiltration;
CARBICARB CHURCH & DWIGHT CO., INC. Law Department 500 Charles Ewing Boulevard Ewing NJ 08628 Pharmaceutical solutions used in dialysis;
CITPRIZMA GAMBRO LUNDIA AB 16 Magistratsvagen Lund 22643 Sweden Pharmaceutical solutions used in dialysis, namely, dialysis fluids, dialysis substitution fluids or concentrates, all being for use in hemodialysis, hemofiltration or hemodiafiltration;
EDI (ENDOTHELIAL DAMAGE INHIBITOR) Somahlution 225 Chimney Corner Lane, Suite 2001 Jupiter FL 33458 Pharmaceutical solutions used in dialysis;ENDOTHELIAL DAMAGE INHIBITOR;
LOCALSATE GAMBRO LUNDIA AB 16 Magistratsvagen Lund 22643 Sweden Pharmaceutical solutions used in dialysis, namely, dialysis fluids, dialysis substitution fluids or concentrates, all being for use in hemodialysis, hemofiltration or hemodiafiltration;
MULTIBIC FRESENIUS MEDICAL CARE HOLDINGS, INC. Legal Department - Trademarks 920 Winter Street Waltham MA 02451 Pharmaceutical solutions used in dialysis;PVC-free multi-layered foil compartmentalized mixing bag of sterile solution in the nature of Pharmaceutical solutions used in dialysis for use as replacement parts of a dialysis machine for medical treatment;
OPCALZO GAMBRO LUNDIA AB 16 Magistratsvagen Lund 22643 Sweden Pharmaceutical solutions used in dialysis, namely, dialysis fluids, dialysis substitution fluids or concentrates, all being for use in hemodialysis, hemofiltration or hemodiafiltration;
REGIOCIT GAMBRO LUNDIA AB 16 Magistratsvagen Lund 22643 Sweden Pharmaceutical solutions used in dialysis, namely, dialysis fluids, dialysis substitution fluids or concentrates, all being for use in hemodialysis, hemofiltration or hemodiafiltration;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention provides a peritoneal dialysis solution that contains heat stable osmotic agents such as D-glucitols, gluconic acids and alkylglycosides produced the reduction, oxidation or glycosylation of icodextrins respectively. As a result, osmotic agents that are stable under autoclaving or heat sterilization conditions are provided which reduces the amount of bioincompatible materials in the sterilized peritoneal dialysis solutions. Methods of preparing the D-glucitols, gluconic acids and alkylglycosides are disclosed.